Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-22

Clinical Trial Update: Neutrino Regimen for Treatment-experienced HCV GT1 Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update indicating completed results for the Neutrino Regimen in treatment-experienced hepatitis C genotype 1 patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neutrino Regimen

Snippet

Sponsor: Humanity and Health Research Centre | Conditions: Chronic Hepatitis C Infection | Phase 4 | Status: COMPLETED